A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers
2010

Gene Expression Changes in Breast Cells from Li-Fraumeni Syndrome Patients

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Herbert Brittney-Shea, Chanoux Rebecca A., Liu Yunlong, Baenziger Peter H., Goswami Chirayu P., McClintick Jeanette N., Edenberg Howard J., Pennington Robert E., Lipkin Steven M., Kopelovich Levy

Primary Institution: Indiana University School of Medicine

Hypothesis

Altered gene expression in morphologically normal breast cells from Li-Fraumeni syndrome mutation carriers may reveal biomarkers for cancer risk and targets for chemoprevention.

Conclusion

The study identified significant gene expression changes in normal breast epithelial and stromal cells from Li-Fraumeni syndrome patients, suggesting potential biomarkers for cancer risk.

Supporting Evidence

  • Gene expression profiling revealed distinct patterns between LFS and wild-type cells.
  • Pharmacological intervention with p53 rescue compounds showed changes in gene expression.
  • Altered gene expression was linked to pathways involved in cancer development.

Takeaway

Scientists studied breast cells from people with a genetic condition that increases cancer risk and found changes in how genes work, which could help in finding new ways to prevent cancer.

Methodology

Whole genome expression profiling of primary epithelial and stromal cells from Li-Fraumeni syndrome patients and matched normal samples.

Limitations

The study was limited by the small number of available breast tissue samples from LFS patients.

Participant Demographics

Included two female patients with Li-Fraumeni syndrome, aged 29 and 31, and matched controls.

Statistical Information

P-Value

5.96E-05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication